A detailed history of Engineers Gate Manager LP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 48,604 shares of BBIO stock, worth $1.39 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
48,604
Previous 71,505 32.03%
Holding current value
$1.39 Million
Previous $1.81 Million 31.7%
% of portfolio
0.03%
Previous 0.04%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$23.91 - $31.3 $547,562 - $716,801
-22,901 Reduced 32.03%
48,604 $1.24 Million
Q2 2024

Aug 14, 2024

BUY
$23.0 - $31.04 $572,930 - $773,206
24,910 Added 53.46%
71,505 $1.81 Million
Q1 2024

May 15, 2024

BUY
$27.35 - $40.45 $461,148 - $682,027
16,861 Added 56.71%
46,595 $1.44 Million
Q4 2023

Feb 14, 2024

BUY
$24.02 - $43.89 $31,730 - $57,978
1,321 Added 4.65%
29,734 $1.2 Million
Q3 2023

Nov 14, 2023

BUY
$16.89 - $35.01 $479,895 - $994,739
28,413 New
28,413 $749,000
Q4 2022

Feb 14, 2023

BUY
$6.74 - $11.52 $130,944 - $223,810
19,428 Added 103.85%
38,136 $290,000
Q3 2022

Nov 14, 2022

SELL
$7.94 - $12.36 $442,194 - $688,353
-55,692 Reduced 74.85%
18,708 $186,000
Q2 2022

Aug 15, 2022

BUY
$5.21 - $12.14 $306,556 - $714,317
58,840 Added 378.15%
74,400 $676,000
Q1 2022

May 16, 2022

SELL
$7.34 - $17.16 $228,530 - $534,276
-31,135 Reduced 66.68%
15,560 $158,000
Q4 2021

Feb 14, 2022

BUY
$11.38 - $53.41 $471,405 - $2.21 Million
41,424 Added 785.89%
46,695 $779,000
Q3 2021

Nov 15, 2021

BUY
$46.87 - $64.24 $247,051 - $338,609
5,271 New
5,271 $247,000

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $4.23B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.